As of 2024-12-13, the Intrinsic Value of RELIEF THERAPEUTICS Holding SA (RLF.SW) is (29,880.39) CHF. This RLF.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.98 CHF, the upside of RELIEF THERAPEUTICS Holding SA is -750,863.50%.

The range of the Intrinsic Value is (206,531.15) - (16,189.13) CHF

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(206,531.15) - (16,189.13)	(29,880.39)	-750863.5%
DCF (Growth 10y)	(340,789.75) - (4,821,595.17)	(662,141.56)	-16636822.6%
DCF (EBITDA 5y)	(5,962.31) - (12,015.60)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(130,112.78) - (288,203.53)	(1,234.50)	-123450.0%
Fair Value	-18.44 - -18.44	-18.44	-563.22%
P/E	(55.09) - (57.74)	(51.07)	-1383.1%
EV/EBITDA	(3.32) - (8.63)	(6.11)	-253.5%
EPV	(24.07) - (36.19)	(30.13)	-857.0%
DDM - Stable	(48.43) - (717.43)	(382.93)	-9721.4%
DDM - Multi	(11,772.19) - (137,989.41)	(21,858.55)	-549309.9%